Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

N James Topper


  • Large Shareholder, Director at Phathom Pharmaceuticals Inc. (PHAT), 2020-06-16
  • Director at Aptinyx Inc. (APTX), 2020-04-02
  • Large Shareholder at Passage Bio Inc. (PASG), 2020-03-03
  • Large Shareholder, Director at Anaptysbio Inc (ANAB), 2020-02-13
  • Large Shareholder at Arcutis Biotherapeutics Inc. (ARQT), 2020-02-06
  • Large Shareholder at Entasis Therapeutics Holdings Inc. (ETTX), 2020-01-13
  • Large Shareholder, Director at Alpine Immune Sciences Inc. (ALPN), 2020-01-07
  • Large Shareholder at Mirum Pharmaceuticals Inc. (MIRM), 2019-07-24
  • Large Shareholder, Director at Allena Pharmaceuticals Inc. (ALNA), 2019-06-07
  • Large Shareholder, Director at Sierra Oncology Inc. (SRRA), 2017-02-16
  • Large Shareholder at Glaukos Corp (GKOS), 2015-06-30
  • Large Shareholder at Collegium Pharmaceutical Inc (COLL), 2015-05-14
  • Director at Amicus Therapeutics Inc (FOLD), 2014-06-16
  • Director at Portola Pharmaceuticals Inc (PTLA), 2013-06-07
  • Director at La Jolla Pharmaceutical Co (LJPC), 2009-02-26
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALPN $5.37 372,439 Large Shareholder, Director 2,571,450 2019-01-18 Filing
ETTX $15.00 375,887 Large Shareholder, Director 1,349,953 2018-09-28 Filing
APTX $16.00 150,000 Large Shareholder, Director 3,190,079 2018-06-25 Filing
ALNA $14.00 500,000 Large Shareholder, Director 3,330,373 2017-11-06 Filing
SRRA $1.35 5,925,926 Large Shareholder, Director 5,925,926 2017-02-14 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
LJPC $0.06 2,756,711 Director 0 2009-02-26 Filing
LJPC $0.06 1,454,000 Director 2,756,711 2009-02-25 Filing
LJPC $0.07 1,662,000 Director 4,210,711 2009-02-24 Filing